Greenwich LifeSciences (GLSI) executive compensation, 2025 proxy

Snehal Patel, Chief Executive Officer, was paid $6.2M in 2024, up 127% from $2.8M the year before.

Open GLSI in Gloom →
Greenwich LifeSciences' chart, financials and news, free in your browser.Open GLSI in Gloom →
Filed
November 3, 2025
Annual meeting
December 18, 2025
Pay year
2024
Named executives
1
CEO total pay
$6.2M+127% vs prior year
CEO pay in equity
85%$5.3M in awards
CEO salary
$612,5632024 reported salary
CEO bonus
$306,281Deferred bonus compensation
CEO stock awards
$5,322,841Largest compensation component
Options granted
630,0002024 grant
Maximum annual bonus
50%Of then-base salary
2023 CEO total
$2,750,028Prior-year reported total

How Patel was paid

$6.2M in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary10%Bonus5%Stock awards85%

Named executive officers

ExecutiveTotal
Snehal PatelChief Executive Officer$6,241,685

What changed and why

  • $6.2M$6,241,685 CEO total compensation in 2024 versus $2,750,028 in 2023.
  • $5.3M$5,322,841 stock awards represented the largest reported component of 2024 CEO compensation.
  • $306K$306,281 deferred bonus compensation was reported for 2024.
  • 630,000 stock options were granted for services rendered and future-service incentives.
  • 50%50% of base salary was the maximum annual bonus opportunity under the CEO employment agreement.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.